GRANULES INDIA
|
GRANULES INDIA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 21.34 | 16.64 | 22.18 | 13.19 | 9.30 |
| CEPS(Rs) | 28.97 | 23.04 | 28.30 | 17.58 | 11.53 |
| DPS(Rs) | 1.50 | 1.50 | 1.50 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 116.38 | 103.62 | 86.85 | 71.80 | 59.73 |
| Tax Rate(%) | 24.82 | 26.03 | 21.99 | 27.19 | 32.20 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 20.24 | 19.17 | 21.65 | 17.96 | 16.17 |
| EBIT Margin(%) | 16.47 | 15.44 | 18.49 | 15.48 | 12.85 |
| Pre Tax Margin(%) | 15.23 | 14.82 | 17.83 | 14.55 | 11.65 |
| PAT Margin (%) | 11.45 | 10.96 | 13.91 | 10.60 | 7.90 |
| Cash Profit Margin (%) | 15.54 | 15.18 | 17.74 | 15.28 | 12.34 |
| Performance Ratios | |||||
| ROA(%) | 10.97 | 10.04 | 15.84 | 9.99 | 6.64 |
| ROE(%) | 19.18 | 17.49 | 27.64 | 18.54 | 13.32 |
| ROCE(%) | 19.63 | 17.37 | 25.42 | 17.22 | 12.71 |
| Asset Turnover(x) | 0.96 | 0.92 | 1.14 | 0.94 | 0.84 |
| Sales/Fixed Asset(x) | 1.66 | 1.63 | 1.97 | 1.75 | 1.78 |
| Working Capital/Sales(x) | 5.93 | 4.36 | 4.80 | 3.98 | 6.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.60 | 0.61 | 0.51 | 0.57 | 0.56 |
| Receivable days | 75.78 | 81.94 | 65.94 | 83.34 | 100.03 |
| Inventory Days | 86.07 | 85.35 | 56.39 | 51.34 | 51.03 |
| Payable days | 112.38 | 114.29 | 117.79 | 96.93 | 86.90 |
| Valuation Parameters | |||||
| PER(x) | 13.62 | 18.40 | 13.67 | 10.89 | 12.29 |
| PCE(x) | 10.04 | 13.29 | 10.72 | 8.17 | 9.91 |
| Price/Book(x) | 2.50 | 2.96 | 3.49 | 2.00 | 1.91 |
| Yield(%) | 0.52 | 0.49 | 0.49 | 0.70 | 0.87 |
| EV/Net Sales(x) | 1.73 | 2.20 | 2.50 | 1.64 | 1.67 |
| EV/Core EBITDA(x) | 8.39 | 11.19 | 9.16 | 7.58 | 9.27 |
| EV/EBIT(x) | 10.47 | 14.25 | 11.06 | 9.41 | 12.48 |
| EV/CE(x) | 1.59 | 1.84 | 2.18 | 1.32 | 1.28 |
| M Cap / Sales | 1.56 | 2.02 | 2.32 | 1.40 | 1.28 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.84 | 16.29 | 24.59 | 14.02 | 35.29 |
| Core EBITDA Growth(%) | 25.38 | -16.13 | 56.99 | 36.80 | 41.99 |
| EBIT Growth(%) | 27.85 | -20.45 | 61.41 | 48.30 | 43.26 |
| PAT Growth(%) | 25.16 | -24.88 | 77.30 | 65.14 | 60.94 |
| EPS Growth(%) | 28.24 | -24.98 | 68.17 | 41.87 | 78.01 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.38 | 0.43 | 0.39 | 0.49 | 0.65 |
| Current Ratio(x) | 1.42 | 1.53 | 1.70 | 1.82 | 1.43 |
| Quick Ratio(x) | 0.79 | 0.93 | 1.04 | 1.33 | 1.00 |
| Interest Cover(x) | 13.29 | 25.04 | 27.80 | 16.75 | 10.72 |
| Total Debt/Mcap(x) | 0.15 | 0.14 | 0.11 | 0.24 | 0.34 |
Compare Financial Ratios of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹10,285.0 Cr | 2.3% | -1.6% | 40.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
| CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 2.3% |
-1.6% |
40.3% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
